Pfizer CentreOne CPhI Barcelona Pfizer CentreOne CPhI Barcelona

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Annexon Biosciences

    Client Virtual Booth

    ANNEXON BIOSCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Annexon Biosciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    180 Kimball Way, 2nd Floor, Suite 200 South San Francisco, CA 94080
    Telephone
    Telephone
    650.822.5500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://annexonbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/annexon-biosciences
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Annexon Biosciences to Participate in 2023 Cantor Global Healthcare Conference
    Annexon Biosciences to Participate in 2023 Cantor Global Healthcare Conference

    https://www.globenewswire.com//news-release/2023/09/19/2745419/0/en/Annexon-Biosciences-to-Participate-in-the-2023-Cantor-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    19 Sep 2023
    Share Share
    Annexon Reports Inducement Grant to Employee Under Nasdaq Rule 5635(c)(4)
    Annexon Reports Inducement Grant to Employee Under Nasdaq Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2023/09/18/2745172/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    18 Sep 2023
    Share Share
    Annexon Highlights Reports Second Quarter 2023 Financial Results
    Annexon Highlights Reports Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/07/2719531/0/en/Annexon-Highlights-Recent-Pipeline-and-Business-Progress-and-Reports-Second-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    07 Aug 2023
    Share Share
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(c)(4)
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2023/08/02/2717317/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Aug 2023
    Share Share
    Annexon finds more silver linings in failed eye disease trial
    Annexon finds more silver linings in failed eye disease trial

    https://www.fiercebiotech.com/biotech/annexon-finds-more-silver-linings-failed-eye-disease-trial-ahead-talks-fda

    Nick Paul Taylor FIERCE BIOTECH
    31 Jul 2023
    Share Share
    Annexon Presents ARCHER Trial Results at ASRS Highlighting Potential of ANX007
    Annexon Presents ARCHER Trial Results at ASRS Highlighting Potential of ANX007

    https://www.globenewswire.com/news-release/2023/07/30/2714521/0/en/Annexon-Presents-ARCHER-Trial-Results-at-ASRS-2023-Highlighting-Potential-of-ANX007-as-a-Differentiated-Treatment-for-Geographic-Atrophy.html

    GLOBENEWSWIRE
    30 Jul 2023
    Share Share
    Annexon Biosciences Appointed Jamie Dananberg as Chief Medical Officer
    Annexon Biosciences Appointed Jamie Dananberg as Chief Medical Officer

    https://www.globenewswire.com/news-release/2023/07/27/2711977/0/en/Annexon-Biosciences-Strengthens-Leadership-Team-with-Appointment-of-Jamie-Dananberg-M-D-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    27 Jul 2023
    Share Share
    Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS
    Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS

    https://www.globenewswire.com/news-release/2023/07/24/2709360/0/en/Annexon-to-Report-ARCHER-Phase-2-Trial-Results-in-Geographic-Atrophy-at-ASRS-2023.html

    GLOBENEWSWIRE
    24 Jul 2023
    Share Share
    Annexon eye disease med failed phase 2 goal—the CEO is thrilled
    Annexon eye disease med failed phase 2 goal—the CEO is thrilled

    https://www.fiercebiotech.com/biotech/annexons-eye-disease-med-improved-vision-phase-2-trial-flunked-primary-goal-ceo-was

    Max Bayer FIERCE BIOTECH
    25 May 2023
    Share Share
    Annexon reports topline results from Phase II trial of GA therapy
    Annexon reports topline results from Phase II trial of GA therapy

    https://www.clinicaltrialsarena.com/news/annexon-results-ga-therapy/

    CLINICAL TRIALS ARENA
    25 May 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    seqens-2023-10-02

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search